This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical: Archive
3 Highly Ranked Medical Stocks Added to the Zacks Strong Buy List
by Shaun Pruitt
Considering the stretched premiums many groundbreaking healthcare companies can command, these medical stocks are worthy of investors' interest given their attractive P/E valuations and the positive trend of earnings estimate revisions.
HAENegative Net Change LNTHPositive Net Change OPCHPositive Net Change
earnings investing medical medical-devices
Do Options Traders Know Something About Acadia Healthcare (ACHC) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Acadia Healthcare (ACHC) stock based on the movements in the options market lately.
ACHCPositive Net Change
medical
Intuitive Surgical (ISRG) Stock Gains 20% YTD: Here's Why
by Zacks Equity Research
Intuitive Surgical (ISRG) shares gain on the back of growth in the da Vinci treatment volume and raised procedure prices.
BSXPositive Net Change ECLPositive Net Change ISRGNegative Net Change ALGNPositive Net Change
medical medical-devices
3 Medical Info Systems Stocks to Buy as GenAI Transforms Healthcare
by Urmimala Biswas
Zacks Medical Info Systems industry stocks like Hims & Hers Health (HIMS), Enovis Corporation (ENOV) and Health Catalyst (HCAT) are expected to gain from the GenAI wave.
HIMSNegative Net Change HCATPositive Net Change ENOVPositive Net Change
artificial-intelligence medical medical-devices
Candel (CADL) Stock Skyrockets 431% Year to Date: Here's Why
by Zacks Equity Research
Candel (CADL) surges 431% in the year-to-date period, driven by positive developmental and regulatory updates from the clinical program for CAN-2409 across two different cancer indications.
ENTXNegative Net Change ANVSPositive Net Change ALXONegative Net Change CADLPositive Net Change
biotechnology biotechs medical pharmaceuticals
Moderna (MRNA) Stock Outperformed Industry YTD: Here's Why
by Zacks Equity Research
Shares of Moderna (MRNA) are being driven by encouraging pipeline updates and plans for potential product launches.
MRKPositive Net Change MRNANegative Net Change HRTXPositive Net Change ARQTNegative Net Change
biotechs medical messenger-rna pharmaceuticals vaccines
Exact Sciences (EXAS) to Showcase Favorable Research Outcome
by Zacks Equity Research
Exact Sciences' (EXAS) latest study research result shows commitment to innovation and strategies that expand access to effective cancer screening and diagnostic tools for patients.
RMDNegative Net Change EXASPositive Net Change MEDPPositive Net Change EHCPositive Net Change
medical medical-devices
Best Momentum Stocks to Buy for May 28th
by Zacks Equity Research
MNSO, LSPD and HAE made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 28, 2023.
HAENegative Net Change LSPDNegative Net Change MNSONegative Net Change
medical
Reasons to Retain Cardinal Health (CAH) in Your Portfolio Now
by Zacks Equity Research
Cardinal Health (CAH) gains from a solid pharmaceutical segment and a diversified product portfolio. Gross margins improve. However, the rising cost of products is a concern.
DVANegative Net Change ALGNPositive Net Change CAHPositive Net Change EHCPositive Net Change
medical medical-devices
What's in Store for Cooper Companies (COO) in Q2 Earnings?
by Zacks Equity Research
Cooper Companies' (COO) fiscal second-quarter results are likely to reflect segmental strength.
UHSPositive Net Change THCPositive Net Change COOPositive Net Change BWAYNegative Net Change
medical medical-devices
Zacks Initiates Coverage of UTMD With Neutral Recommendation
by Debasmita Chatterjee
Explore why Zacks rates UTMD with a "Neutral" recommendation, being the first on Wall Street to initiate coverage on the stock. Learn about UTMD's financial stability, diverse product portfolio, and market opportunities, balanced against key challenges in the competitive medical device industry.
UTMDPositive Net Change
medical
Here's Why Investors Should Retain ICON (ICLR) Stock Now
by Zacks Equity Research
Investors remain optimistic about ICON (ICLR) due to its impressive strategic pacts and stable solvency.
RMDNegative Net Change ICLRPositive Net Change MEDPPositive Net Change HIMSNegative Net Change
medical medical-devices
Zacks.com featured highlights include Carlisle Companies, ResMed, Booz Allen Hamilton and CrediCorp
by Zacks Equity Research
Carlisle Companies, ResMed, Booz Allen Hamilton and CrediCorp are part of the Zacks Screen of the Week article.
RMDNegative Net Change CSLPositive Net Change BAHPositive Net Change BAPPositive Net Change
business-services finance medical multi-sector-conglomerates
Apellis (APLS) Posts Upbeat One-Year Kidney Diseases Study Data
by Zacks Equity Research
Apellis (APLS) reports positive one-year data from the mid-stage study evaluating systemic pegcetacoplan to treat two rare and debilitating kidney diseases.
APLSNegative Net Change ENTXNegative Net Change ANVSPositive Net Change ALXONegative Net Change
biotechnology biotechs medical pharmaceuticals
Cigna's (CI) Express Scripts Collaborates With CPESN USA
by Zacks Equity Research
Cigna's (CI) Express Scripts collaborates with CPESN USA in a bid to enhance care delivery for hypertension and diabetes patients.
CIPositive Net Change BKDPositive Net Change HQYPositive Net Change SERANegative Net Change
medical
Merus (MRUS) Surges 36% on Head & Neck Cancer Antibody Data
by Zacks Equity Research
Data from an earlier cut-off date shows that treatment with Merus' (MRUS) combination therapy achieved a 60% response rate in patients with head and neck cancer.
HRTXPositive Net Change MRNSNegative Net Change MRUSNegative Net Change ARQTNegative Net Change
biotechs medical
ResMed (RMD) Up 16.3% Since Last Earnings: Will it Continue?
by Zacks Equity Research
Investors are optimistic about ResMed (RMD) led by strong growth in the U.S. mask and accessories business and its cloud-connected platforms.
BSXPositive Net Change ECLPositive Net Change ALGNPositive Net Change RMDNegative Net Change
medical medical-devices
Inari Medical (NARI) Sues Truvic on Patent Infringement
by Zacks Equity Research
Inari Medical (NARI) files a patent infringement lawsuit against Imperative Care and its subsidiary Truvic over intentionally copying and overlapping the designs of Inari Medical's products.
BSXPositive Net Change ECLPositive Net Change ALGNPositive Net Change NARINegative Net Change
medical medical-devices
Stereotaxis (STXS) Gets CE Recertification for Approved Products
by Zacks Equity Research
Stereotaxis' (STXS) receives updated EU Quality Management System Certificate, which demonstrates compliance with MDR.
RMDNegative Net Change STXSNegative Net Change MEDPPositive Net Change HIMSNegative Net Change
medical
5 Hospital Stocks Set to Gain From Robust Industry Trends
by Kaibalya Pravo Dey
The Zacks Medical-Hospital industry is gaining from growing patient volumes, utilization rates and technological advancements. Companies like HCA, THC, UHS, ACHC and CYH are expected to gain from these trends.
HCAPositive Net Change UHSPositive Net Change THCPositive Net Change CYHPositive Net Change ACHCPositive Net Change
hospitals medical
5 Stocks Trading Near 52-Week High That Can Climb Further
by Vasundhara Sawalka
Investors target stocks that have been on a bullish run lately. Stocks like WWW, SIG, THC, LPX and SIMO that are seeing price strength have a high chance of carrying the momentum forward.
THCPositive Net Change LPXPositive Net Change SIGPositive Net Change WWWNegative Net Change SIMONegative Net Change
construction consumer-discretionary medical retail tech-stocks
Reasons to Hold Cencora (COR) Stock in Your Portfolio for Now
by Zacks Equity Research
Cencora (COR) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
BSXPositive Net Change ECLPositive Net Change DVANegative Net Change CORPositive Net Change
medical medical-devices
Here's Why You Should Buy Boston Scientific (BSX) Stock Now
by Zacks Equity Research
Investors continue to be optimistic about Boston Scientific (BSX) due to its geographical expansions and impressive acquisitions.
BSXPositive Net Change RMDNegative Net Change MEDPPositive Net Change HIMSNegative Net Change
medical medical-devices
UnitedHealth Unit (UNH) Wins Medicaid Deal to Serve Kansas
by Zacks Equity Research
UnitedHealth Group (UNH) receives a contract from the State of Kansas to provide enhanced care to beneficiaries of the KanCare program and gain a greater Medicaid customer base.
UNHPositive Net Change CNCPositive Net Change LMATPositive Net Change ELVPositive Net Change
medical
Encompass Health (EHC) JV Opens Atlanta Rehabilitation Hospital
by Zacks Equity Research
The new facility in Georgia marks the 162nd inpatient rehabilitation hospital of Encompass Health (EHC) in the country.
BKDPositive Net Change HQYPositive Net Change EHCPositive Net Change SERANegative Net Change
medical